rss

Author index

January 2004, Volume 59, Issue 1

[Table of contents]
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abe, S

    • Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist Thorax 2004;59:1 31-38 doi:10.1136/thx.2003.000893

  2. Agustsson, Th

    • Effect of delays on prognosis in patients with non-small cell lung cancer Thorax 2004;59:1 45-49

B

  1. Barnes, N

    • British guidelines on the management of asthma
      1. Commentator:
        • B G Higgins,
        • J G Douglas,
        • and N Barnes
      Thorax 2004;59:1 81-82

  2. Beasley, R

    • Clinical dose-response relationship of fluticasone propionate in adults with asthma Thorax 2004;59:1 16-20

  3. Bendayan, D

    • Multidrug resistant tuberculosis following lung transplantation: treatment with pulmonary resection Thorax 2004;59:1 79-80

  4. Boyton, R J

    • Pneumocystis pneumonia in humans is caused by P jiroveci not P carinii
      1. Commentator:
        • R J Boyton,
        • D M Mitchell,
        • and O M Kan
      Thorax 2004;59:1 83-84

  5. Brusasco, V

    • Peak flow meters still useful but require consistency rather than accuracy
      1. Commentator:
        • V Brusasco
      Thorax 2004;59:1 82-83

  6. Burrows, N J

    • Pulmonary artery aneurysm and tuberous sclerosis Thorax 2004;59:1 86 doi:10.1136/thx.2003.016634

C

  1. Chiba, H

    • Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist Thorax 2004;59:1 31-38 doi:10.1136/thx.2003.000893

  2. Chida, M

    • Effects of antiplatelet agents on pulmonary haemodynamic response to fMLP in endotoxin primed rats Thorax 2004;59:1 39-44 doi:10.1136/thx.2003.002022

  3. Clancy, K

    • British guidelines on the management of asthma
      1. Commentator:
        • B G Higgins,
        • J G Douglas,
        • and N Barnes
      Thorax 2004;59:1 81-82

  4. Connolly, C K

    • Peak flow meters still useful but require consistency rather than accuracy
      1. Commentator:
        • V Brusasco
      Thorax 2004;59:1 82-83

  5. Costeloe, K

    • Low birth weight for gestation and airway function in infancy: exploring the fetal origins hypothesis Thorax 2004;59:1 60-66

  6. Cullinan, P

    • Early prescriptions of antibiotics and the risk of allergic disease in adults: a cohort study Thorax 2004;59:1 11-15

  7. Currie, G P

    • The use of opioids for palliative care in refractory dyspnoea Thorax 2004;59:1 7 doi:10.1136/thx.2003.la66
    • Environmental nitrogen dioxide causes a pro-allergic response in the bronchial epithelium of normal subjects in vivo Thorax 2004;59:1 10 doi:10.1136/thx.2003.la69

D

  1. Davies, R J O

    • Sleep · 1: Obstructive sleep apnoea/hypopnoea syndrome: definitions, epidemiology, and natural history Thorax 2004;59:1 73-78 doi:10.1136/thx.2003.007161

  2. Dezateux, C

    • Low birth weight for gestation and airway function in infancy: exploring the fetal origins hypothesis Thorax 2004;59:1 60-66

  3. Dick, M

    • Pulmonary function abnormalities in children with sickle cell disease Thorax 2004;59:1 67-70

  4. Dicpinigaitis, P V

    • Cough · 4: Cough in asthma and eosinophilic bronchitis Thorax 2004;59:1 71-72

  5. Douglas, J G

    • British guidelines on the management of asthma
      1. Commentator:
        • B G Higgins,
        • J G Douglas,
        • and N Barnes
      Thorax 2004;59:1 81-82

  6. Dower, S K

    • Toll-like receptor (TLR) 4 polymorphisms and COPD Thorax 2004;59:1 81

E

  1. Elliott, M W

    • Time course of changes in driving simulator performance with and without treatment in patients with sleep apnoea hypopnoea syndrome Thorax 2004;59:1 56-59

  2. Estela del Río-Navarro, B

    • Genetic polymorphism of GSTM1 and antioxidant supplementation influence lung function in relation to ozone exposure in asthmatic children in Mexico City Thorax 2004;59:1 8-10

F

  1. Figg, J

    • Early prescriptions of antibiotics and the risk of allergic disease in adults: a cohort study Thorax 2004;59:1 11-15

  2. Fleetham, J

    • Sleep disordered breathing Sleep disordered breathing awoken Thorax 2004;59:1 5-6 doi:10.1136/thx.2003.009407

  3. Fogarty, A

    • Antioxidants and asthma The developing story of antioxidants and asthma Thorax 2004;59:1 3-4

  4. Forman, D

G

  1. Greenough, A

    • Pulmonary function abnormalities in children with sickle cell disease Thorax 2004;59:1 67-70

H

  1. Hall, I

    • Toll-like receptor (TLR) 4 polymorphisms and COPD Thorax 2004;59:1 81

  2. Harris, J

    • Early prescriptions of antibiotics and the risk of allergic disease in adults: a cohort study Thorax 2004;59:1 11-15

  3. Harrison, T W

    • Use of sequential quadrupling dose regimens to study efficacy of inhaled corticosteroids in asthma Thorax 2004;59:1 21-25 doi:10.1136/thx.2003.015289
    • Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide Thorax 2004;59:1 26-30 doi:10.1136/thx.2003.015297

  4. Hawdon, J

    • Low birth weight for gestation and airway function in infancy: exploring the fetal origins hypothesis Thorax 2004;59:1 60-66

  5. Hernández-Avila, M

    • Genetic polymorphism of GSTM1 and antioxidant supplementation influence lung function in relation to ozone exposure in asthmatic children in Mexico City Thorax 2004;59:1 8-10

  6. Higgins, B G

    • British guidelines on the management of asthma
      1. Commentator:
        • B G Higgins,
        • J G Douglas,
        • and N Barnes
      Thorax 2004;59:1 81-82

  7. Hillerdal, G

    • Effect of delays on prognosis in patients with non-small cell lung cancer Thorax 2004;59:1 45-49

  8. Holt, S

    • Clinical dose-response relationship of fluticasone propionate in adults with asthma Thorax 2004;59:1 16-20

  9. Hoo, A-F

    • Low birth weight for gestation and airway function in infancy: exploring the fetal origins hypothesis Thorax 2004;59:1 60-66

  10. Hoshikawa, Y

    • Effects of antiplatelet agents on pulmonary haemodynamic response to fMLP in endotoxin primed rats Thorax 2004;59:1 39-44 doi:10.1136/thx.2003.002022

  11. Hubbard, R

    • Antioxidants and asthma The developing story of antioxidants and asthma Thorax 2004;59:1 3-4
    • Toll-like receptor (TLR) 4 polymorphisms and COPD Thorax 2004;59:1 81

J

  1. Johnson, S R

    • Pulmonary artery aneurysm and tuberous sclerosis Thorax 2004;59:1 86 doi:10.1136/thx.2003.016634

  2. Johnston, S L

    • Reviewers Thank you to all Thorax reviewers Thorax 2004;59:1 6-7 doi:10.1136/thx.2003.018689

K

  1. Kan, O M

    • Pneumocystis pneumonia in humans is caused by P jiroveci not P carinii
      1. Commentator:
        • R J Boyton,
        • D M Mitchell,
        • and O M Kan
      Thorax 2004;59:1 83-84

  2. Karthik, S

    • Adenocarcinoma of lung presenting with dysgeusia Thorax 2004;59:1 84 doi:10.1136/thx.2004.001479

  3. Kiely, J L

    • Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis Thorax 2004;59:1 50-55

  4. Kondo, T

    • Effects of antiplatelet agents on pulmonary haemodynamic response to fMLP in endotoxin primed rats Thorax 2004;59:1 39-44 doi:10.1136/thx.2003.002022

  5. Kramer, M R

    • Multidrug resistant tuberculosis following lung transplantation: treatment with pulmonary resection Thorax 2004;59:1 79-80

  6. Kubo, H

    • Effects of antiplatelet agents on pulmonary haemodynamic response to fMLP in endotoxin primed rats Thorax 2004;59:1 39-44 doi:10.1136/thx.2003.002022

L

  1. Lambe, M

    • Effect of delays on prognosis in patients with non-small cell lung cancer Thorax 2004;59:1 45-49

  2. Lamberg, K

    • Effect of delays on prognosis in patients with non-small cell lung cancer Thorax 2004;59:1 45-49

  3. Lewis, S

    • Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide Thorax 2004;59:1 26-30 doi:10.1136/thx.2003.015297

  4. London, S J

    • Genetic polymorphism of GSTM1 and antioxidant supplementation influence lung function in relation to ozone exposure in asthmatic children in Mexico City Thorax 2004;59:1 8-10

  5. Lum, S

    • Low birth weight for gestation and airway function in infancy: exploring the fetal origins hypothesis Thorax 2004;59:1 60-66

M

  1. Masoli, M

    • Clinical dose-response relationship of fluticasone propionate in adults with asthma Thorax 2004;59:1 16-20

  2. McNicholas, W T

    • Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis Thorax 2004;59:1 50-55

  3. Mediratta, N K

    • Adenocarcinoma of lung presenting with dysgeusia Thorax 2004;59:1 84 doi:10.1136/thx.2004.001479

  4. Miller, R

    • Pneumocystis pneumonia in humans is caused by P jiroveci not P carinii
      1. Commentator:
        • R J Boyton,
        • D M Mitchell,
        • and O M Kan
      Thorax 2004;59:1 83-84

  5. Milligan, P

    • Pulmonary function abnormalities in children with sickle cell disease Thorax 2004;59:1 67-70

  6. Mills, P

    • Early prescriptions of antibiotics and the risk of allergic disease in adults: a cohort study Thorax 2004;59:1 11-15

  7. Mitchell, D M

    • Reviewers Thank you to all Thorax reviewers Thorax 2004;59:1 6-7 doi:10.1136/thx.2003.018689
    • Pneumocystis pneumonia in humans is caused by P jiroveci not P carinii
      1. Commentator:
        • R J Boyton,
        • D M Mitchell,
        • and O M Kan
      Thorax 2004;59:1 83-84

  8. Moffat, S

    • Early prescriptions of antibiotics and the risk of allergic disease in adults: a cohort study Thorax 2004;59:1 11-15

  9. Mohan, K

    • Bilateral diagnostic thoracocentesis may not be routinely indicated in patients with bilateral pleural effusion Thorax 2004;59:1 55

  10. Moody, A

  11. Moon, A

    • Early prescriptions of antibiotics and the risk of allergic disease in adults: a cohort study Thorax 2004;59:1 11-15

  12. Moreno-Macías, H

    • Genetic polymorphism of GSTM1 and antioxidant supplementation influence lung function in relation to ozone exposure in asthmatic children in Mexico City Thorax 2004;59:1 8-10

  13. Muers, M

  14. Myrdal, G

    • Effect of delays on prognosis in patients with non-small cell lung cancer Thorax 2004;59:1 45-49

N

  1. Newman Taylor, A J

    • Early prescriptions of antibiotics and the risk of allergic disease in adults: a cohort study Thorax 2004;59:1 11-15

  2. Nolan, P

    • Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis Thorax 2004;59:1 50-55

O

  1. Oborne, J

    • Use of sequential quadrupling dose regimens to study efficacy of inhaled corticosteroids in asthma Thorax 2004;59:1 21-25 doi:10.1136/thx.2003.015289
    • Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide Thorax 2004;59:1 26-30 doi:10.1136/thx.2003.015297

  2. Otsuka, M

    • Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist Thorax 2004;59:1 31-38 doi:10.1136/thx.2003.000893

P

  1. Patey, R A

    • Pulmonary function abnormalities in children with sickle cell disease Thorax 2004;59:1 67-70

  2. Phillips, K

    • Use of sequential quadrupling dose regimens to study efficacy of inhaled corticosteroids in asthma Thorax 2004;59:1 21-25 doi:10.1136/thx.2003.015289
    • Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide Thorax 2004;59:1 26-30 doi:10.1136/thx.2003.015297

R

  1. Rafferty, G F

    • Pulmonary function abnormalities in children with sickle cell disease Thorax 2004;59:1 67-70

  2. Ramírez-Aguilar, M

    • Genetic polymorphism of GSTM1 and antioxidant supplementation influence lung function in relation to ozone exposure in asthmatic children in Mexico City Thorax 2004;59:1 8-10

  3. Rees, D

    • Pulmonary function abnormalities in children with sickle cell disease Thorax 2004;59:1 67-70

  4. Reyes-Ruiz, N I

    • Genetic polymorphism of GSTM1 and antioxidant supplementation influence lung function in relation to ozone exposure in asthmatic children in Mexico City Thorax 2004;59:1 8-10

  5. Romieu, I

    • Genetic polymorphism of GSTM1 and antioxidant supplementation influence lung function in relation to ozone exposure in asthmatic children in Mexico City Thorax 2004;59:1 8-10

  6. Roop, R

    • Adenocarcinoma of lung presenting with dysgeusia Thorax 2004;59:1 84 doi:10.1136/thx.2004.001479

S

  1. Sabroe, I

    • Toll-like receptor (TLR) 4 polymorphisms and COPD Thorax 2004;59:1 81

  2. Saralaya, D

    • Time course of changes in driving simulator performance with and without treatment in patients with sleep apnoea hypopnoea syndrome Thorax 2004;59:1 56-59

  3. Saute, M

    • Multidrug resistant tuberculosis following lung transplantation: treatment with pulmonary resection Thorax 2004;59:1 79-80

  4. Schünemann, H

    • Is there an association between impaired pulmonary function and mortality in never smokers? Thorax 2004;59:1 81

  5. Shaw, D

    • New evidence for the Dutch hypothesis? Thorax 2004;59:1 38 doi:10.1136/thx.2003.la67

  6. Shiratori, M

    • Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist Thorax 2004;59:1 31-38 doi:10.1136/thx.2003.000893

  7. Shitrit, D

    • Multidrug resistant tuberculosis following lung transplantation: treatment with pulmonary resection Thorax 2004;59:1 79-80

  8. Sienra-Monge, J J

    • Genetic polymorphism of GSTM1 and antioxidant supplementation influence lung function in relation to ozone exposure in asthmatic children in Mexico City Thorax 2004;59:1 8-10

  9. Sircar, M

    • Time course of changes in driving simulator performance with and without treatment in patients with sleep apnoea hypopnoea syndrome Thorax 2004;59:1 56-59

  10. Song, C

    • Effects of antiplatelet agents on pulmonary haemodynamic response to fMLP in endotoxin primed rats Thorax 2004;59:1 39-44 doi:10.1136/thx.2003.002022

  11. Ståhle, E

    • Effect of delays on prognosis in patients with non-small cell lung cancer Thorax 2004;59:1 45-49

  12. Stocks, J

    • Low birth weight for gestation and airway function in infancy: exploring the fetal origins hypothesis Thorax 2004;59:1 60-66

  13. Stradling, J R

    • Sleep · 1: Obstructive sleep apnoea/hypopnoea syndrome: definitions, epidemiology, and natural history Thorax 2004;59:1 73-78 doi:10.1136/thx.2003.007161

  14. Suzuki, S

    • Effects of antiplatelet agents on pulmonary haemodynamic response to fMLP in endotoxin primed rats Thorax 2004;59:1 39-44 doi:10.1136/thx.2003.002022

  15. Sylvester, K P

    • Pulmonary function abnormalities in children with sickle cell disease Thorax 2004;59:1 67-70

T

  1. Tabata, T

    • Effects of antiplatelet agents on pulmonary haemodynamic response to fMLP in endotoxin primed rats Thorax 2004;59:1 39-44 doi:10.1136/thx.2003.002022

  2. Takahashi, H

    • Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist Thorax 2004;59:1 31-38 doi:10.1136/thx.2003.000893

  3. Tattersfield, A E

    • Use of sequential quadrupling dose regimens to study efficacy of inhaled corticosteroids in asthma Thorax 2004;59:1 21-25 doi:10.1136/thx.2003.015289
    • Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide Thorax 2004;59:1 26-30 doi:10.1136/thx.2003.015297

  4. Thein, S L

    • Pulmonary function abnormalities in children with sickle cell disease Thorax 2004;59:1 67-70

  5. Turkington, P M

    • Time course of changes in driving simulator performance with and without treatment in patients with sleep apnoea hypopnoea syndrome Thorax 2004;59:1 56-59

W

  1. Weatherall, M

    • Clinical dose-response relationship of fluticasone propionate in adults with asthma Thorax 2004;59:1 16-20

  2. Wedzicha, J A

    • Reviewers Thank you to all Thorax reviewers Thorax 2004;59:1 6-7 doi:10.1136/thx.2003.018689

  3. Wedzicha, Wisia

  4. White, C

    • Early prescriptions of antibiotics and the risk of allergic disease in adults: a cohort study Thorax 2004;59:1 11-15

  5. White, V L C

    • Can inactivated Mycobacterium vaccae vaccine help protect HIV positive patients against tuberculosis? Thorax 2004;59:1 38 doi:10.1136/thx.2003.la68

  6. Whyte, M K B

    • Toll-like receptor (TLR) 4 polymorphisms and COPD Thorax 2004;59:1 81

  7. Wilson, A G

    • Toll-like receptor (TLR) 4 polymorphisms and COPD Thorax 2004;59:1 81

Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Thorax.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.